awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51098678-0B5E576A-05FD-4589-84AA-3D06A6937FE8
Q51098678-0B5E576A-05FD-4589-84AA-3D06A6937FE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51098678-0B5E576A-05FD-4589-84AA-3D06A6937FE8
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-M
P2860
Q51098678-0B5E576A-05FD-4589-84AA-3D06A6937FE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51098678-0B5E576A-05FD-4589-84AA-3D06A6937FE8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e2dbfa10823fc2277cce3c49310341b71399a731
P2860
Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia.